Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 6
Submit an article Journal homepage
95
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Glioblastoma multiforme: can neural stem cells deliver the therapeutic payload and fulfill the clinical promise?

Atique U Ahmed The University of Chicago Brain Tumor Center, University of Chicago, Chicago, IL, USA
&
Maciej S Lesniak The University of Chicago Brain Tumor Center, University of Chicago, Chicago, IL, USA and Section of Neurosurgery, The University of Chicago Pritzker School of Medicine, 5841 South Maryland Ave., MC 3026, Chicago, IL 60637, USA. [email protected]
Pages 775-777 | Published online: 09 Jan 2014

References

  • Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl Acad. Sci. USA97(23), 12846–12851 (2000).
  • Benedetti S, Pirola B, Pollo B et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med.6(4), 447–450 (2000).
  • Joo KM, Park IH, Shin JY et al. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol. Ther. (3), 570–575 (2009).
  • Aboody KS, Bush RA, Garcia E et al. Development of a tumor-selective approach to treat metastatic cancer. PLoS One1, e23 (2006).
  • Sims TL Jr, Hamner JB, Bush RA et al. Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis. J. Pediatr. Surg.44(1), 204–210; discussion 210–211 (2009).
  • Einstein O, Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch. Neurol.65(4), 452–456 (2008).
  • Ahmed AU, Thaci B, Alexiades NG et al. Neural stem cell-based carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthoptopic mouse model of human glioblastoma. Mol. Ther. (2011) (In press).
  • Ahmed AU, Alexiades NG, Lesniak MS. The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. Curr. Opin. Mol. Ther.12(5), 546–552 (2010).
  • Le S. FDA approves first human neural stem cell clinical trial to treat brain tumors. Synapse54(1), 1–2 (2010).
  • Tyler MA, Ulasov IV, Sonabend AM et al. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther.16(2), 262–278 (2009).
  • Frank RT, Edmiston M, Kendall SE et al. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS One4(12), e8314 (2009).
  • Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One5(3), e9750 (2010).
  • Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther.15(10), 739–752 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.